Contact
searchSearch
HMP Global

Acid-Related Disorders News

News
Patient Response to Corticosteroids for EoE May Be Tied to BMI
09/27/2023
New research suggests that a patient’s weight could affect responses to topical corticosteroids used in the treatment of eosinophilic esophagitis.
New research suggests that a patient’s weight could affect responses to topical corticosteroids used in the treatment of eosinophilic esophagitis.
New research suggests that a...
09/27/2023
Gastroenterology
News
Do PPIs Raise Risk of Infection Among Children?
09/06/2023
Investigators recommend using proton pump inhibitors for pediatric patients only when there is a clear indication of a gastric disorder.
Investigators recommend using proton pump inhibitors for pediatric patients only when there is a clear indication of a gastric disorder.
Investigators recommend using...
09/06/2023
Gastroenterology
News
Association of Dementia With PPIs Disputed
08/04/2023
A recent post-hoc analysis casts doubt on earlier research that suggested proton pump inhibitors (PPIs) may place older patients at risk of developing dementia.
A recent post-hoc analysis casts doubt on earlier research that suggested proton pump inhibitors (PPIs) may place older patients at risk of developing dementia.
A recent post-hoc analysis casts...
08/04/2023
Gastroenterology
News
Rapid Test Detects H Pylori With High Accuracy, Sensitivity
02/02/2023
Researchers cite “unprecedented performance” of a point-of-care test that looks for 2 antibodies.
Researchers cite “unprecedented performance” of a point-of-care test that looks for 2 antibodies.
Researchers cite “unprecedented...
02/02/2023
Gastroenterology
News
Predictive Ability of H. Pylori Risk Factors Reviewed
11/22/2022
The performance of risk factors for Helicobacter pylori in clinical practice was largely unknown until the publication of a recent study.
The performance of risk factors for Helicobacter pylori in clinical practice was largely unknown until the publication of a recent study.
The performance of risk factors...
11/22/2022
Gastroenterology
News
Is Vonoprazan Effective in Healing Erosive Esophagitis?
11/02/2022
Researchers investigated vonoprazan as an effective alternative to lansoprazole for treating patients with erosive esophagitis.
Researchers investigated vonoprazan as an effective alternative to lansoprazole for treating patients with erosive esophagitis.
Researchers investigated...
11/02/2022
Gastroenterology
News
Observing Guidelines for GERD Can Reduce Symptoms in Women
09/29/2022
The Nurses’ Health Study shows that regular exercise and dietary changes can help some patients avoid medication for gastroesophageal reflux disease.
The Nurses’ Health Study shows that regular exercise and dietary changes can help some patients avoid medication for gastroesophageal reflux disease.
The Nurses’ Health Study shows...
09/29/2022
Gastroenterology
News
Study Assesses Effectiveness of Antibiotics in Treating H. Pylori
09/15/2022
The increasing resistance of Helicobacter pylori to antibiotics led researchers to compare 2 regimens of 3 therapies to conduct systematic review and meta-analysis to assess effectiveness.
The increasing resistance of Helicobacter pylori to antibiotics led researchers to compare 2 regimens of 3 therapies to conduct systematic review and meta-analysis to assess effectiveness.
The increasing resistance of...
09/15/2022
Gastroenterology
News
ACG Updates Guideline for GERD
09/06/2022
Key concepts and recommendations cover diagnosis and management of gastroesophageal reflux disease, citing new developments.
Key concepts and recommendations cover diagnosis and management of gastroesophageal reflux disease, citing new developments.
Key concepts and recommendations...
09/06/2022
Gastroenterology
News
H Pylori Eradication Reduces Gastric Cancer Risk
08/17/2022
Helicobacter pylori infection is considered the most important risk factor in the pathogenesis of gastric cancer.
Helicobacter pylori infection is considered the most important risk factor in the pathogenesis of gastric cancer.
Helicobacter pylori infection is...
08/17/2022
Gastroenterology

Sign up for our e-Newsletters

Gastroenterology Newsletter

News

News
Colonoscopy After Diverticulitis Usually Unnecessary
11/14/2024
In colonoscopies performed solely for diverticulitis, the CRC prevalence was just 0.17%, the study found.
In colonoscopies performed solely for diverticulitis, the CRC prevalence was just 0.17%, the study found.
In colonoscopies performed...
11/14/2024
Gastroenterology
News
Upper Gl Mucosal Damage Associated With Parkinson's Disease
10/18/2024
Upper gastrointestinal (GI) mucosal damage was associated with elevated risk of developing Parkinson's disease.
Upper gastrointestinal (GI) mucosal damage was associated with elevated risk of developing Parkinson's disease.
Upper gastrointestinal (GI)...
10/18/2024
Gastroenterology
News
Vonoprozan Compared to PPIs for Peptic Ulcer Rebleeding Prevention
10/18/2024
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
Vonoprazan offers an effective...
10/18/2024
Gastroenterology
News
NAFLD or MASLD? Research Looks at Concordance of Criteria
10/18/2024
New nomenclature shows strong applicability in real-world clinical settings.
New nomenclature shows strong applicability in real-world clinical settings.
New nomenclature shows strong...
10/18/2024
Gastroenterology
News
Liver Histology Impact on Long-Term Clinical Outcomes in MASH
10/18/2024
Results showed that a lower fibrosis stage (F0–1) was associated with a significantly reduced risk of cirrhosis and liver-related outcomes compared to patients with advanced fibrosis (F4).
Results showed that a lower fibrosis stage (F0–1) was associated with a significantly reduced risk of cirrhosis and liver-related outcomes compared to patients with advanced fibrosis (F4).
Results showed that a lower...
10/18/2024
Gastroenterology
News
AI-Enabled Electrocardiogram Shows Promise in Predicting MASLD
10/18/2024
Researchers explored the use of an artificial intelligence model to detect metabolic dysfunction–associated steatotic liver disease.
Researchers explored the use of an artificial intelligence model to detect metabolic dysfunction–associated steatotic liver disease.
Researchers explored the use of...
10/18/2024
Gastroenterology
News
New Age Recommendation Yields Uptake in CRC Screening But Disparities Found
10/18/2024
Income level and location drove variations in rates of increase, authors of a retrospective cohort study found.
Income level and location drove variations in rates of increase, authors of a retrospective cohort study found.
Income level and location drove...
10/18/2024
Gastroenterology
News
Repeat FIT Offers Greater Differentiation of Patients With, Without Significant Pathology
10/09/2024
Conducting repeat fecal immunochemical tests doubled the detection rates of colorectal cancer and significant bowel disease, researchers reported.
Conducting repeat fecal immunochemical tests doubled the detection rates of colorectal cancer and significant bowel disease, researchers reported.
Conducting repeat fecal...
10/09/2024
Gastroenterology
News
AI-Enabled Electrocardiogram Shows Promise in Predicting MASLD
10/08/2024
Researchers explored the use of an artificial intelligence model to detect metabolic dysfunction–associated steatotic liver disease.
Researchers explored the use of an artificial intelligence model to detect metabolic dysfunction–associated steatotic liver disease.
Researchers explored the use of...
10/08/2024
Gastroenterology
News
FDA Approves Cologuard Plus
10/07/2024
The U.S. Food and Drug Administration (FDA) on October 4 approved the Cologuard Plus multitarget stool DNA test for adults ages 45 and older who are average risk for colorectal cancer.
The U.S. Food and Drug Administration (FDA) on October 4 approved the Cologuard Plus multitarget stool DNA test for adults ages 45 and older who are average risk for colorectal cancer.
The U.S. Food and Drug...
10/07/2024
Gastroenterology

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use